Intercept Pharmaceuticals... (ICPT)
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 9:00 PM
0.21% (1D)
| Bid | n/a |
| Market Cap | 794.69M |
| Revenue (ttm) | 317.68M |
| Net Income (ttm) | -58.61M |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | -17.431192660550458 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 3,906,002 |
| Avg. Volume (20D) | 2,054,565 |
| Open | 19.00 |
| Previous Close | 18.96 |
| Day's Range | 18.98 - 19.01 |
| 52-Week Range | 8.82 - 21.86 |
| Beta | 0.88 |
About ICPT
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 11, 2012
Employees 341
Stock Exchange NASDAQ
Ticker Symbol ICPT
Website https://www.interceptpharma.com